Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL34 pseudogene 36 (RPL34P36) is classified as a pseudogene, specifically related to the ribosomal protein L34 (RPL34), but is not transcribed into a functional protein nor implicated in any pathway, cellular process, or disease mechanism[7][9][11]. Pseudogenes like RPL34P36 arise from gene duplication or retrotransposition events; they often display DNA sequence homology to their parent genes but are typically non-functional due to mutations or lack of regulatory elements. In the human genome, multiple pseudogenes exist for ribosomal protein genes, complicating some genomic analyses but not contributing directly to protein-coding or therapeutic mechanisms[5][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL34 pseudogene 36 (RPL34P36).